Structural basis for aminoacylation of cellular modified tRNALys3 by human lysyl-tRNA synthetase
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Swapnil C Devarkar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, United States. Hauptthemen laut MEDLINE: Lysine-tRNA Ligase, Transfer RNA Aminoacylation, RNA, Transfer, Lys. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, Office of Biological and Environmental Research.
Abstract (Originalsprache)
The average eukaryotic transfer ribonucleic acid (tRNA) contains 13 post-transcriptional modifications; however, their functional impact is largely unknown. Our understanding of the complex tRNA aminoacylation machinery in metazoans also remains limited. Herein, using a series of high-resolution cryo-electron microscopy (cryo-EM) structures, we provide the mechanistic basis for recognition and aminoacylation of fully modified cellular tRNALys3 by human lysyl-tRNA synthetase (h-LysRS). The tRNALys3 anticodon loop modifications S34 (mcm5s2U) and R37 (ms2t6A) play an integral role in recognition by h-LysRS. Modifications in the T-, variable-, and D-loops of tRNALys3 are critical for ordering the metazoan-specific N-terminal domain of LysRS. The two catalytic steps of tRNALys3 aminoacylation are structurally ordered; docking of the 3′-CCA end in the active site cannot proceed until the lysyl–adenylate intermediate is formed and the pyrophosphate byproduct is released. Association of the h-LysRS–tRNALys3 complex with a multi-tRNA synthetase complex-derived peptide shifts the equilibrium toward the 3′-CCA end “docked” conformation and allosterically increases h-LysRS catalytic efficiency. The insights presented here have broad implications for understanding the role of tRNA modifications in protein synthesis, the human aminoacylation machinery, and the growing catalog of metabolic and neurological diseases linked to it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, United States.
- Department of Chemistry and Biochemistry, Center for RNA Biology, and Center for Retrovirus Research, Ohio State University, Columbus, OH 43210, United States.
- Rieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, OH 45221, United States.
ORCID-Profile: Swapnil C Devarkar
Förderung
- NIH HHS
- NIAID NIH HHS
- Office of Biological and Environmental Research
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Devarkar, S. C., Budding, C. R., Pathirage, C., Kavoor, A., Herbert, C., Limbach, P. A., Musier-Forsyth, K., & Xiong, Y. (2025). Structural basis for aminoacylation of cellular modified tRNALys3 by human lysyl-tRNA synthetase. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf114
Vancouver
Devarkar SC, Budding CR, Pathirage C, Kavoor A, Herbert C, Limbach PA, et al. Structural basis for aminoacylation of cellular modified tRNALys3 by human lysyl-tRNA synthetase. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf114
BibTeX
@article{Devarkar2025,
author = {Devarkar, Swapnil C and Budding, Christina R and Pathirage, Chathuri and Kavoor, Arundhati and Herbert, Cassandra and Limbach, Patrick A and Musier-Forsyth, Karin and Xiong, Yong},
title = {Structural basis for aminoacylation of cellular modified tRNALys3 by human lysyl-tRNA synthetase},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf114}
}
EUVIMED